Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
FAK (PTK2) is a non-receptor protein-tyrosine kinase which is involved in regulation of a number of essential cellular processes, including cell cycle progression, cell migration, actic cytoskeleton organisation and formation of focal adhesions. FAK is activated by phosphorylation and recruited to focal adhesions in response to integrin signalling. Aberrant expression of FAK may play a role in tumor formation, including ovarian, breast and non-small cell lung cancers.
- WB
Supplier Data
Western blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (AB322354)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of phosphorylated FAK is upregulated in response to pervanadate treatment (PMID : 20847951).
In Western blot, Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade (ab176842) staining at 1/100000 dilution.
In Western blot, Anti-FAK antibody [EP695Y] (ab40794) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (ab322354) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
HeLa treated with 10μM pervanadate for 60 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated HeLa whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 4:
HeLa treated with 10μM pervanadate for 60 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 119 kDa,15 kDa
false
Exposure time: 8s
- Dot
Supplier Data
Dot Blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (AB322354)
Dot blot analysis of FAK (phospho Y397 + Y576 + Y925) using ab322354 at 1 : 1000 (0.515 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane1 : Human FAK (phospho Y397) peptide
Lane2 : Human FAK non-phospho peptide
Lane3 : Human FAK (phospho Y576) peptide
Lane4 : Human FAK non-phospho peptide
Lane5 : Human FAK (phospho Y925) peptide
Lane6 : Human FAK non-phospho peptide
Exposure time : 180 seconds.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Dot Blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (ab322354) at 1/1000 dilution
Lane 1:
Human FAK (phospho Y397) peptide
Lanes 2, 4 and 6:
Human FAK non-phospho peptide
Lane 3:
Human FAK (phospho Y576) peptide
Lane 5:
Human FAK (phospho Y925) peptide
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (AB322354)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of phosphorylated FAK is upregulated in response to pervanadate treatment (PMID : 20847951).
In Western blot, Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade (ab176842) staining at 1/100000 dilution.
In Western blot, Anti-FAK antibody [EP695Y] (ab40794) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (ab322354) at 1/1000 dilution
Lane 1:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
NIH/3T3 treated with 10μM pervanadate for 60 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated NIH/3T3 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 4:
NIH/3T3 treated with 10μM pervanadate for 60 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 119 kDa,15 kDa
false
Exposure time: 8s
- WB
Supplier Data
Western blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (AB322354)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The activation of phosphorylation of FAK is reported to be related to developmental processes in brain tissue (PMID : 14642275). So expression level of phosphorylated modified FAK in normal brain is quite low causing not easy to be detected. We suggest optimizing experimental protocols (increasing lysate amount, using lower dilution or higher-sensitivity ECL substrate) to improve results.
FAK can be cleaved at several sites. The molecular weight observed is consistent with what has been described in the literature (PMID : 10545505, PMID : 9642276).
This blot of Lane 2 and 4 was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-FAK antibody [EP695Y] (ab40794) staining at 1/1000 dilution.
Exposure time : Lane 1, 3 : 136 seconds; Lane 2, 4 : 70 seconds
All lanes:
Western blot - Anti-FAK (phospho Y397 + Y576 + Y925) antibody [RM1141] (ab322354) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate (untreated membrane) at 40 µg
Lane 2:
Rat brain tissue lysate (untreated membrane) at 40 µg
Lane 3:
Mouse brain tissue lysate (alkaline phosphatase treated membrane) at 40 µg
Lane 4:
Rat brain tissue lysate (alkaline phosphatase treated membrane) at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 119 kDa,36 kDa
false
Reactivity data
Product details
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Alternative Names
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com